1579 Results

People

  1. Cheung
    Cheung
  2. Wolchok
    Wolchok
  3. Postow
    Postow
  4. Hellmann
    Hellmann
  5. Adusumilli
    Adusumilli
  6. Old
    Old
  7. Livingston
    Livingston
  8. Motzer
    Motzer
  9. Slovin
    Slovin
  10. Houghton
    Houghton

Groups

  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)
  7. Center for Hematologic Malignancies (221)
  8. Surgery (221)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (191)
  10. Melanoma Disease Management Team (186)
  1. "immunotherapy"
Formats
  1. Journal Article (1126)
  2. Review (243)
  3. Editorial (60)
  4. Meeting Abstract (57)
  5. Book Section (30)
  6. Guidelines (28)
  7. Research Letter (14)
  8. Conference Paper (9)
  9. Correspondence (7)
  10. Miscellaneous (5)
Groups
  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)

More Groups

People
  1. Jedd Wolchok (107)
  2. Nai-Kong Cheung (71)
  3. Michael Postow (67)
  4. Matthew Hellmann (53)
  5. Prasad Adusumilli (39)
  6. Michel Sadelain (36)

More People

Years
  1. 2025 (69)
  2. 2024 (160)
  3. 2023 (135)
  4. 2022 (134)
  5. 2021 (129)
  6. 2020 (102)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (117)
  2. Journal of Thoracic Oncology (55)
  3. Clinical Cancer Research (41)
  4. Annals of Oncology (35)
  5. Cancer Immunology, Immunotherapy (29)
  6. Cancer (28)

More Publications

Publishers
  1. Elsevier Inc. (242)
  2. Biomed Central Ltd (139)
  3. Springer (103)
  4. Wiley Blackwell (83)
  5. American Association for Cancer Research (69)
  6. Oxford University Press (67)

More Publishers

Results (1579)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cabozantinib plus nivolumab in patients with non–clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Journal Article

    Fitzgerald, K. N.; Lee, C. H.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y.; Lefkowitz, R. A.; Shah, N. J.; Owens, C. N.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Current evidences in poorly differentiated thyroid carcinoma: A systematic review and subsection meta-analysis for clinical decision making
    Review

    Chatterjee, S.; Mair, M.; Shaha, A. R.; Paleri, V.; Sawhney, S.; Mishra, A.; Bhandarkar, S.; D’Cruz, A. K.
    Endocrine (2024)

    Fulltext@MSK | Save
  • The role of surgery for stage IV melanoma
    Review

    Dann, A. M.; Ariyan, C.
    Advances in Surgery (2024)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Journal Article

    Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Epigenetic therapy in a rare ovarian cancer - A double-edged sword
    Correspondence

    Hsu, C.; Konner, J. A.; Gounder, M. M.
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Toxicity of immune checkpoint inhibitors and tyrosine kinase inhibitor combinations in solid tumours: A systematic review and meta-analysis
    Review

    O’Reilly, D.; O’Leary, C. L.; Reilly, A.; Teo, M. Y.; O’Kane, G.; Hendriks, L.; Bennett, K.; Naidoo, J.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
    Journal Article

    Liu, S. Y.; Erazo, T.; Jee, J.; Arfe, A.; Gupta, A.; Pike, L. R. G.; Santini, F. C.; Daly, B.; Schoenfeld, A.; Eichholz, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Evaluating immune checkpoint blockade in metastatic castration-resistant prostate cancers with deleterious CDK12 alterations in the phase 2 IMPACT trial
    Journal Article

    Nguyen, C. B.; Reimers, M. A.; Perera, C.; Abida, W.; Chou, J.; Feng, F. Y.; Antonarakis, E. S.; McKay, R. R.; Pachynski, R. K.; Zhang, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • The intestinal microbiota and therapeutic responses to immunotherapy
    Review

    Herrera, P. S.; van den Brink, M.
    Annual Review of Cancer Biology (2024)

    Fulltext@MSK | Save
  • Induction therapy for non–small cell lung cancer
    Editorial

    Cooper, A.; Chaft, J. E.; Bott, M. J.
    Journal of Thoracic and Cardiovascular Surgery (2024)

    Fulltext@MSK | Save